Clinical Trials Browser

Lung Diseases, Interstitial × pembrolizumab × 90 days × Clear all

NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Phase 2 Not yet recruiting

Lung Diseases, Interstitial